Related Experiment Video
Updated: Jul 20, 2026

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4
Espen Aberg1, Maria Perander, Bjarne Johansen
1Department of Pharmacology, Institute of Medical Biology, University of Tromsø, N-9037 Tromsø, Norway, and Cancer Research UK Stress Response Laboratory, Biomedical Research Centre, Ninewells Hospital and Medical School, Dundee, UK.
Abstract:
MAPK-activated protein kinase 5 (MK5) was recently identified as a physiological substrate of the atypical MAPK ERK3. Complex formation between ERK3 and MK5 results in phosphorylation and activation of MK5, concomitant stabilization of ERK3, and the nuclear exclusion of both proteins. However, ablation of ERK3 in HeLa cells using small interfering RNA or in fibroblasts derived from ERK3 null mice reduces the activity of endogenous MK5 by only 50%, suggesting additional mechanisms of MK5 regulation. Here we identify the ERK3-related kinase ERK4 as a bona fide interaction partner of MK5. Binding of ERK4 to MK5 is accompanied by phosphorylation and activation of MK5. Furthermore, complex formation also results in the relocalization of MK5 from nucleus to cytoplasm. However unlike ERK3, ERK4 is a stable protein, and its half-life is not modified by the presence or absence of MK5. Finally, although knock-down of ERK4 protein in HeLa cells reduces endogenous MK5 activity by approximately 50%, a combination of small interfering RNAs targeting both ERK4 and ERK3 causes a further reduction in the MK5 activity by more than 80%. We conclude that MK5 activation is dependent on both ERK3 and ERK4 in these cells and that these atypical MAPKs are both physiological regulators of MK5 activity.
Insights
MAPK-activated protein kinase 5 (MK5) is regulated by both ERK3 and ERK4. These atypical MAPKs phosphorylate and activate MK5, influencing its stability and cellular localization.
Area of Science:
- Cellular signaling pathways
- Protein kinase regulation
- Mitogen-activated protein kinases (MAPKs)
Background:
- MAPK-activated protein kinase 5 (MK5) is a known substrate of the atypical MAPK ERK3.
- ERK3 binding to MK5 leads to MK5 activation, ERK3 stabilization, and nuclear exclusion of both proteins.
- ERK3 ablation partially reduces MK5 activity, indicating other regulatory mechanisms.
Purpose of the Study:
- To identify additional physiological regulators of MK5 activity.
- To investigate the role of ERK4, an ERK3-related kinase, in MK5 regulation.
Main Methods:
- Small interfering RNA (siRNA) mediated knockdown of ERK3 and ERK4 in HeLa cells.
- Analysis of endogenous MK5 activity and protein levels.
- Co-immunoprecipitation assays to assess protein-protein interactions.
- Studies using fibroblasts from ERK3 null mice.
Main Results:
- ERK4 directly interacts with MK5, leading to MK5 phosphorylation and activation.
- ERK4 binding causes MK5 relocalization from the nucleus to the cytoplasm.
- Knockdown of ERK4 alone reduces MK5 activity by approximately 50%.
- Combined knockdown of ERK3 and ERK4 reduces MK5 activity by over 80%.
Conclusions:
- MK5 activation is dependent on both ERK3 and ERK4.
- ERK3 and ERK4 act as physiological regulators of MK5 activity.
- These findings reveal a dual MAPK regulatory mechanism for MK5.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway
Regulation of the Unfolded Protein Response

